Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.067 | 0.7 |